Brazilian soybean producers’ group Aprosoja, representing 240,000 farmers, on Tuesday, August 10, criticized federal antitrust agency CADE’s decision to clear a joint venture formed by rivals Bayer AG, Corteva, and Syngenta.
The joint venture was approved by CADE unconditionally last week and offers a platform for the collection of royalties from genetically modified soybeans in Brazil.
The farmers’ group complained that CADE ignored its misgivings about the venture, which it claims will perpetuate a royalties collection system long opposed by local growers.
Cultive Biotec, as the JV is known, stated it will make more soy biotechnologies available in Brazil. It also stated it will stimulate competition among biotechnology developers and increase the competitiveness of Brazil’s farm sector, which will have more seed biotechnologies to choose from.
CADE stated it strives to maintain competition, guaranteeing the diversity and quality of products and services offered to consumers.
Tuesday’s statement by Aprosoja underscores tensions between soy farmers and biotechnology companies operating in Brazil, the world’s biggest producer and exporter of that oilseed and other agricultural commodities like coffee and sugar.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Turkey Hits Meta with $37.20 Million Fine Over Data-Sharing Practices
May 8, 2024 by
CPI
Google Seeks Dismissal of UK Suit Over Alleged Anti-Competitive Practices
May 8, 2024 by
CPI
Redfin Settles $9.2M Commission Inflation Lawsuits
May 7, 2024 by
CPI
DOJ Supports Colorado’s Efforts to Block Kroger-Albertsons Merger
May 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI